Evidence review

BPC-157 vs PPIs: Healing vs Suppressing Acid

#peptide#topic
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-vs-ppi-comparison`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-vs-ppi-comparison

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-vs-ppi-comparison/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-vs-ppi-comparison/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-vs-ppi-comparison/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-vs-ppi-comparison/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why BPC-157 might help you

  1. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.
  2. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
  3. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • BPC-157 → structure / tissue

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 12
  • Claims tagged human evidence: 7
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 48
  • Reddit posts catalogued: 34
  • X posts catalogued: 11
  • Other anecdote sources (YouTube, Instagram, etc.): 2
  • Total sources in chain: 59

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors (source s1)

Human review on PPI risks including microbiome and deficiencies.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Long-term Use of PPIs Has Consequences for Gut Microbiome (source s2)

Cleveland Clinic summary of PPI microbiome effects.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The beneficial effect of BPC 157... on gastric and duodenal lesions... in rats (source s3)

1994 rat study on BPC-157 gastroprotection.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Stable gastric pentadecapeptide BPC 157: novel therapy in... gastrointestinal lesions (source s4)

Review of rat GI healing studies.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Regeneration or Risk? A Narrative Review of BPC-157 (source s5)

Confirms limited human data, none for gut healing.

Evidence type: Published research.

The effect of pentadecapeptide BPC 157, H-2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation (source s6)

Compares BPC-157 angiogenic and granulation effects favorably to omeprazole and H2 blockers in wound healing models; BPC-157 promotes more granulation tissue.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC-157 for GERD: Healing Esophagus & Stopping Acid Reflux (source s7)

Discusses BPC-157 healing esophagus and restoring sphincter function vs PPIs only suppressing acid; includes user anecdotes and research summaries.

Evidence type: Published research.

Multifunctionality and Possible Medical Application of the Pentadecapeptide BPC 157 (source s11)

2025 review on BPC-157 multifunctionality including wound healing and angiogenesis, relevant to GI repair vs acid suppression.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and ... (source s12)

2025 review on BPC-157 healing various GI lesions, including implications for esophageal and sphincter issues vs acid suppression.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic ... (source s13)

2024 review detailing BPC-157's pleiotropic effects on GI healing and sphincter function.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Esophagogastric anastomosis in rats: Improved healing by ... (source s14)

2016 study showing BPC-157 improves healing in esophageal anastomosis models.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Stable Gastric Pentadecapeptide BPC 157 and Wound ... (source s19)

Review on BPC-157 wound healing including GI applications.

Evidence type: Published research.

What people say on Reddit

Bpc 157 oral : r/GERD — Reddit, r/GERD (source s8)

User anecdotes on combining oral BPC-157 with PPIs for GERD/esophagitis healing and reducing PPI dose.

BPC-157 Seems to Be Helping : r/GERD — Reddit, r/GERD (source s9)

Reddit user reports BPC-157 helping GERD symptoms after stopping PPIs due to side effects.

ENOUGH IS ENOUGH! : r/GERD — Reddit, r/GERD (source s15)

User discussing considering BPC-157 for GERD gut healing.

BPC157 and IBS : r/bpc_157 — Reddit, r/bpc_157 (source s16)

Detailed anecdotal report of oral BPC-157 resolving acid reflux and IBS symptoms.

My cure: bpc157 : r/GERD — Reddit, r/GERD (source s17)

Anecdote claiming BPC-157 cured GERD allowing PPI cessation.

Oral BPC-157 Has Given Me the First Symptom-Free ... — Reddit, r/bpc_157 (source s20)

User reports complete resolution of acid reflux with oral BPC-157, eliminating need for PPIs like Prilosec/omeprazole. Positive healing outcome vs suppression.

BPC and healing esophagus from Gerd. — Reddit, r/bpc_157 (source s21)

Discussion on BPC-157 healing esophageal damage from GERD while suggesting continued PPI use short-term; focuses on healing vs symptom masking.

Oral BPC157 for Acid Reflux — Reddit, r/bpc_157 (source s22)

User seeking experiences with oral BPC-157 specifically for GERD/silent reflux symptoms after months of issues.

GERD cured – experience share — Reddit, r/GERD (source s26)

User shares personal GERD experience and recommends oral BPC-157 as helping a lot, contrasting with long-term PPI use. Anecdotal positive outcome for healing vs suppression.

Can we talk BPC-157 for LPR? — Reddit, r/LPR (source s27)

Discussion on BPC-157 for LPR/GERD healing esophageal damage vs PPIs suppressing acid. Includes proposed mechanisms and animal data references. Anecdotal interest in healing.

Bpc and Omeprazole ? — Reddit, r/bpc_157 (source s28)

Thread discussing combining BPC-157 with omeprazole (PPI) for stomach issues. Anecdotal dosing and outcomes for acid-related problems.

Oral BPC-157 vs Glutamine for gut healing? — Reddit, r/Microbiome (source s29)

User reports positive anecdotal results using oral BPC-157 (with glutamine) to fix acid reflux and IBS, allowing shorter use compared to ongoing suppression.

Bpc-157. I've been taking it for approximately 2 weeks. — Reddit, r/GERD (source s30)

Anecdotal report of improved digestion and GERD symptoms after 2 weeks oral BPC-157 250mcg arginate. Positive healing outcome noted.

So frustrated. Oral BPC seems to be making my symptoms worse — Reddit, r/bpc_157 (source s33)

User reports oral BPC-157 worsening severe GERD and gastritis symptoms instead of helping, seeking anecdotes on negative outcomes vs PPIs which also didn't help.

Acid blocker medication ruined my gut health. I have dysbiosis, thrush and anxiety from a PPI. Can bpc-157 help me?? — Reddit, r/bpc_157 (source s34)

Anecdotal report of long-term PPI causing gut dysbiosis, thrush, anxiety, loss of appetite; user hopes BPC-157 can heal the damage (anecdotal, not advice).

Has anyone tried using (Body Protecting Compound) BPC 157 for gastritis? — Reddit, r/Gastritis (source s35)

Comment shares positive anecdotal outcome: oral BPC-157 dosing relieved GERD symptoms (label as anecdotal, not advice); contrasts with PPI suppression.

What people say on X

Peptide Confessions post on BPC-157 for acid reflux — X (source s23)

User describes 15 years on omeprazole (PPI) resolved in 3 weeks with oral BPC-157; highlights healing allowing discontinuation of acid suppression.

X post on BPC-157 accentuating reflux — X (source s24)

Negative outcome: oral BPC-157 worsened acid reflux symptoms for this user with no other benefits noted.

X post on BPC-157 curing reflux — X (source s25)

Positive anecdotal report of decades-long reflux cured in one week with BPC-157 tablets.

X post on BPC-157 for esophagus damage — X (source s31)

Post contrasts BPC-157 healing esophageal damage (citing animal studies) vs PPIs masking symptoms. Recommends oral BPC-157 protocol. Anecdotal advice context.

X post on oral BPC-157 and Barrett's Esophagus — X (source s32)

Query about studies on oral BPC-157 for Barrett's Esophagus (GERD complication), highlighting interest in healing vs acid suppression.

BPC-157 reversed the gut damage NSAIDs do. — X (source s38)

X post contrasts PPIs (suppress/mask acid, ongoing damage) with BPC-157 healing gut lining/esophagus (anecdotal user experience + studies).

BPC-157 and tb-500 orally for gerd? — X (source s43)

Query on oral BPC-157 + TB-500 for GERD (anecdotal interest, no outcome reported).

BPC-157 post on gut repair vs NSAIDs/PPIs — X (source s51)

X post comparing BPC-157 healing to acid-suppressing or masking effects of PPIs/NSAIDs, with anecdotal and study references (anecdotal, not advice).

Oral BPC-157 has changed so many lives — X (source s52)

Post on oral BPC-157 for gut healing, contrasting with PPI suppression, notes anecdotal reports of reduced acid issues (anecdotal, not advice).

Oral BPC-157 for GI irritation from aspirin — X (source s53)

X reply discussing BPC-157 healing gut damage from NSAIDs vs symptomatic suppression, anecdotal context.

X post by @KimberleyRhoa13 — X (source s59)

User mentioning BPC-157 + KPV for acid reflux (anecdotal).

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

Peptide components (collapsible embeds)

BPC-157: Body Protection Compound · structure / tissue · bpc-157
{
  "peptide": "bpc-157",
  "regenerative_layer": "structure / tissue",
  "targets_this_degeneration": "Poor blood supply at injury, weak collagen organization, slow tissue turnover.",
  "proposed_regeneration": "Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.",
  "evidence_in_ledger": {
    "human_claims": 24,
    "preclinical_claims": 4,
    "anecdote_claims": 67,
    "studies_catalogued": 35
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/bpc-157"
}

Regeneration vs degeneration — where this fits The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for step…

Full bpc-157 article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PPIs · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBPC-157 and Corticosteroid Injection-Related Tissue Changes: Evidence… · 6 humanBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation… · 3 humanBPC-157 for Long-Term PPI Users: Evidence Review · 2 humanAOD 9604 for Ppis
Evidence · 59 sources · swipe →chain a00290dfba6a · verify chain · provenance
1 / 59
Evidence ledger 64 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system
BPC-157 vs PPIs: Healing vs Suppressing Acid is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
anecdotal
User describes 15 years on omeprazole (PPI) resolved in 3 weeks with oral BPC-157; highlights healing allowing discontinuation of acid suppression.
sources: s23
anecdotal
Negative outcome: oral BPC-157 worsened acid reflux symptoms for this user with no other benefits noted.
sources: s24
54 more ranked claims
anecdotal0.30
Post contrasts BPC-157 healing esophageal damage (citing animal studies) vs PPIs masking symptoms. Recommends oral BPC-157 protocol. Anecdotal advice context.
grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.30
Query about studies on oral BPC-157 for Barrett's Esophagus (GERD complication), highlighting interest in healing vs acid suppression.
grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
anecdotal0.30
Query on oral BPC-157 + TB-500 for GERD (anecdotal interest, no outcome reported).
grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.30
X post comparing BPC-157 healing to acid-suppressing or masking effects of PPIs/NSAIDs, with anecdotal and study references (anecdotal, not advice).
grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.30
X reply discussing BPC-157 healing gut damage from NSAIDs vs symptomatic suppression, anecdotal context.
grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.30
User mentioning BPC-157 + KPV for acid reflux (anecdotal).
grok-4.3
Materialized from orphan source s59 by ledger repair
sources: s59
human0.22downweightedlow confidence
PPIs reduce gastric acid production and long-term use links to microbiome changes and infection risks in humans.
grok/4.3-populate
Establishes suppression mechanism and human data on consequences.
sources: s1, s2
human0.22low confidence
Compares BPC-157 angiogenic and granulation effects favorably to omeprazole and H2 blockers in wound healing models; BPC-157 promotes more granulation tissue.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
human0.22low confidence
2025 review on BPC-157 multifunctionality including wound healing and angiogenesis, relevant to GI repair vs acid suppression.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
human0.22low confidence
2025 review on BPC-157 healing various GI lesions, including implications for esophageal and sphincter issues vs acid suppression.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
human0.22low confidence
2024 review detailing BPC-157's pleiotropic effects on GI healing and sphincter function.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
human0.22low confidence
A review compares the effects of BPC-157, H2-blockers, omeprazole, and sucralfate on new vessel and granulation tissue formation.
gemini-collaborator
Adds a specific comparative claim from a review regarding BPC-157's mechanistic effects against conventional treatments, enriching the 'who_claims_what' slot.
sources: s6
preclinical0.22low confidence
In rat models, BPC-157 accelerates healing of gastric/duodenal ulcers and promotes angiogenesis.
grok/4.3-populate
Core animal evidence separating from human data.
sources: s3, s4
preclinical0.22low confidence
2016 study showing BPC-157 improves healing in esophageal anastomosis models.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
User anecdotes on combining oral BPC-157 with PPIs for GERD/esophagitis healing and reducing PPI dose.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Reddit user reports BPC-157 helping GERD symptoms after stopping PPIs due to side effects.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
YouTube video analyzing BPC-157 evidence for healing including GI issues, contrasting with conventional treatments like PPIs.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
User discussing considering BPC-157 for GERD gut healing.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Detailed anecdotal report of oral BPC-157 resolving acid reflux and IBS symptoms.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
Anecdote claiming BPC-157 cured GERD allowing PPI cessation.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
Podcast discussing science and studies on BPC-157 for acid reflux management.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
User reports complete resolution of acid reflux with oral BPC-157, eliminating need for PPIs like Prilosec/omeprazole. Positive healing outcome vs suppression.
grok/grok-4.3
Materialized from orphan source s20 by ledger repair
sources: s20
anecdotal0.22low confidence
Discussion on BPC-157 healing esophageal damage from GERD while suggesting continued PPI use short-term; focuses on healing vs symptom masking.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
anecdotal0.22low confidence
User seeking experiences with oral BPC-157 specifically for GERD/silent reflux symptoms after months of issues.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
Positive anecdotal report of decades-long reflux cured in one week with BPC-157 tablets.
grok/grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
anecdotal0.22low confidence
Anecdotal reports of BPC-157's effects on GERD and GI healing come from various online users, including those on Reddit and YouTube, who claim personal experiences with the peptide.
kimi/moonshot-v1-8k
Naming the sources of anecdotal claims provides transparency and allows for better traceability of the evidence presented.
sources: s8, s9, s10
anecdotal0.22low confidence
User shares personal GERD experience and recommends oral BPC-157 as helping a lot, contrasting with long-term PPI use. Anecdotal positive outcome for healing vs suppression.
grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
anecdotal0.22low confidence
Discussion on BPC-157 for LPR/GERD healing esophageal damage vs PPIs suppressing acid. Includes proposed mechanisms and animal data references. Anecdotal interest in healing.
grok-4.3
Materialized from orphan source s27 by ledger repair
sources: s27
anecdotal0.22low confidence
Thread discussing combining BPC-157 with omeprazole (PPI) for stomach issues. Anecdotal dosing and outcomes for acid-related problems.
grok-4.3
Materialized from orphan source s28 by ledger repair
sources: s28
anecdotal0.22low confidence
User reports positive anecdotal results using oral BPC-157 (with glutamine) to fix acid reflux and IBS, allowing shorter use compared to ongoing suppression.
grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
Anecdotal report of improved digestion and GERD symptoms after 2 weeks oral BPC-157 250mcg arginate. Positive healing outcome noted.
grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
User reports oral BPC-157 worsening severe GERD and gastritis symptoms instead of helping, seeking anecdotes on negative outcomes vs PPIs which also didn't help.
grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
anecdotal0.22low confidence
Anecdotal report of long-term PPI causing gut dysbiosis, thrush, anxiety, loss of appetite; user hopes BPC-157 can heal the damage (anecdotal, not advice).
grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Comment shares positive anecdotal outcome: oral BPC-157 dosing relieved GERD symptoms (label as anecdotal, not advice); contrasts with PPI suppression.
grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Comment anecdote: oral BPC-157 didn't allow stopping omeprazole, but injections helped more; good/bad outcomes noted (anecdotal).
grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
anecdotal0.22low confidence
Thread discusses peptides like BPC-157 for healing GERD vs PPIs that mask symptoms; includes rebound GERD mentions.
grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
anecdotal0.22low confidence
X post contrasts PPIs (suppress/mask acid, ongoing damage) with BPC-157 healing gut lining/esophagus (anecdotal user experience + studies).
grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
anecdotal0.22low confidence
User experiments with oral BPC-157 for injury healing and notes potential benefits for GERD/hiatal hernia symptoms; mixed results reported in updates, with fewer symptoms when combined with diet and manipulation.
grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
anecdotal0.22low confidence
Anecdotal report of BPC-157 (oral capsules, 6 weeks) curing GERD long-term after PPI concerns; other users discuss diet, fasting, HCL, and avoiding PPIs.
grok-4.3
Materialized from orphan source s40 by ledger repair
sources: s40
anecdotal0.22low confidence
Anecdotal: Oral BPC-157 + KPV (500 mcg daily) for gastritis/GERD; calmer stomach, no side effects reported after 7 days; functional doctor recommends 2 months.
grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
User combines PPI with BPC-157 for EoE/GERD management; plans to wean PPI while continuing BPC-157; notes uncertainty on BPC contribution amid multiple interventions.
grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
User reports endoscopy improvement after using BPC-157 (anecdotal, not advice); started with multiple erosions, now one smaller. Also mentions blend with KPV, Larazotide etc. Good outcome noted.
grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
anecdotal0.22low confidence
User lists BPC-157 subQ as part of LPR/GERD management stack (anecdotal); hoping for LES healing. Includes PPI use too. No specific outcome yet reported.
grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
anecdotal0.22low confidence
Discussion on oral BPC-157 for reflux/gut support vs injections; anecdotal preference for oral in GERD context.
grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Comment claims BPC-157 resolved GERD/LPR symptoms completely (anecdotal, not advice).
grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
anecdotal0.22low confidence
User discusses mother's long-term PPI use for acid reflux causing side effects like weight issues and bone problems, seeking alternatives.
grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.22low confidence
Discussion on managing LPR/GERD symptoms with PPIs and lifestyle, mentions side effects and alternatives like BPC-157 in context of healing vs suppression.
grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.22low confidence
Lists various treatments including PPIs for acid suppression versus potential healing options, anecdotal experiences shared.
grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
anecdotal0.22low confidence
Post on oral BPC-157 for gut healing, contrasting with PPI suppression, notes anecdotal reports of reduced acid issues (anecdotal, not advice).
grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.22low confidence
User reports acid reflux symptoms decreased immediately with BPC-157 (anecdotal).
grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Discussion on GERD/LPR treatments including mentions of alternatives to PPIs (anecdotal).
grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Anecdotal dosing of oral BPC-157 250-500mcg/day with carnivore diet while on PPIs for long-term GERD (not advice).
grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
User with acid reflux asking about oral BPC-157 for gut (anecdotal inquiry).
grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
anecdotal0.22low confidence
Positive anecdotal outcome with BPC-157 for NSAID ulcers while on omeprazole/PPI; notes side effects from PPIs.
grok-4.3
Materialized from orphan source s58 by ledger repair
sources: s58
Low-confidence / auto-generated 5
speculative0.12
Commercial vendors and clinics market this compound (1 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 7 duplicate marketing claims
sources: s5
speculative0.12
Discusses BPC-157 healing esophagus and restoring sphincter function vs PPIs only suppressing acid; includes user anecdotes and research summaries.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
speculative0.12
Review on BPC-157 wound healing including GI applications.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
speculative0.10
A medical information source claims BPC-157 can heal the esophagus and stop acid reflux, suggesting its use for GERD.
gemini-collaborator
Captures a specific claim from a medical information source about BPC-157's potential therapeutic use for GERD, adding to the 'who_claims_what' slot with a distinct source type.
sources: s7
speculative0.10
Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).
miscsubjects gap analysis
Required constitution slot: what_is_unknown
Model swipes · 20 from 6 models · swipe →verify
1 / 20
grok/grok-4.3writer
redraft2026-06-29 09:06
BPC-157 vs PPIs: Healing vs Suppressing Acid · 3 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-vs-ppis-healing-vs-suppressing-acid",
  "title": "BPC-157 vs PPIs: Healing vs Suppressing Acid",
  "body": "## Acid Suppression by PPIs\n\nPPIs reduce gastric acid production by inhibiting the proton pump in parietal cells. Long-term use is associated with changes in gut microbiome composition and increased risks of infections and nutrient deficiencies (human data from reviews). [web:0][web:1][web:2]\n\n## BPC-157 and Gut Tissue Repair\n\nBPC-157 is a synthetic 15-amino acid peptide derived from a gastric juice protein. In rat models of gastric and duodenal ulcers induced by stress, ethanol, or NSAIDs, BPC-157 administration accelerated lesion healing and promoted angiogenesis (preclinical tier). [web:12][web:7][web:17]\n\nRat studies also show BPC-157 healing intestinal fistulas, improving anastomosis, and counteracting short-bowel syndrome effects through local vascular and tissue remodeling (preclinical tier). [web:7]\n\nNo human clinical trials demonstrate BPC-157 healing of gastric or intestinal lining; available human data are limited to small retrospective reports on joint pain or bladder symptoms and one Phase I safety study (no large-scale gut repair trials reported).\n\n## Repair vs Suppression Framing\n\nPPIs provide symptomatic acid reduction without addressing underlying tissue damage. BPC-157 preclinical findings indicate promotion of new bloo
95caa81ee128e498
grok-4.3source_hunt
sources2026-06-29 11:36
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
8 source(s) added
82ded55661f4d78a
grok-4.3source_hunt
sources2026-06-29 11:36
8 source(s) added · 8 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
8 source(s) added
cf0010f0b08129ca
grok-4.3source_hunt
sources2026-06-29 11:37
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
6 source(s) added
e85f63fce0dc83cd
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
{"materialized":0,"before":[],"after":[]}
28afa21107fb6684
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
{"materialized":0,"before":[],"after":[]}
db3e4231f0ca86a6
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
{"materialized":0,"before":[],"after":[]}
c17fd0298d958737
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
{"materialized":0,"before":[],"after":[]}
57ea565c55d6f6c2
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
{"materialized":0,"before":[],"after":[]}
51ac2e07d4bd4212
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:42
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
I am adding explicit gaps in knowledge (what_is_unknown) regarding BPC-157's effects on the human gastrointestinal system, as well as naming the sources of anecdotal claims where they are not explicitly attributed.
93140240c083eaaf
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 16:31
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
I added two claims to the ledger, specifically populating the 'who_claims_what' slot. The first claim highlights a review that compares BPC-157's effects on tissue formation against conventional treatments, providing a more nuanced understanding of preclinical comparisons. The second claim captures a specific assertion from a medical information source regarding BPC-157's potential for GERD, which is distinct from anecdotal user reports or academic reviews. These additions enhance the ledger's comprehensiveness by detailing who is making what claims from various types of sources within the provided topology. I am not Grok; I am focused on adding specific, sourced claims to the ledger based on the provided topology.
9f9f52e4a1afdfe4
grok-4.3source_hunt
sources2026-06-29 18:50
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
6 source(s) added
00b1dc83d997028e
grok-4.3source_hunt
sources2026-06-29 18:50
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
6 source(s) added
01af3dbb6c35fb1f
grok-4.3source_hunt
sources2026-06-29 18:51
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
5 source(s) added
1d7f22ad9fa03cd2
grok-4.3source_hunt
sources2026-06-29 18:52
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
4 source(s) added
dbf22ad0684c2c54
grok-4.3source_hunt
sources2026-06-29 18:53
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
6 source(s) added
61218bc696770547
grok-4.3source_hunt
sources2026-06-29 18:53
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison
it output
6 source(s) added
5fa0cf2c8c59c08a
fill-slotsclaim_post
claim2026-06-29 21:24
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison c70
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
762b81da768563d5
fill-slotsclaim_post
claim2026-06-29 21:24
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison c70
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
c235dd766b25541b
fill-slotsclaim_post
claim2026-06-29 21:24
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-vs-ppi-comparison c70
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
1e378f0a124b81a4

Related research

PPIs · drug map

Open evidence map →
BPC-157: Body Protection Compoundembedded in this articlebpc-157AOD 9604 for Ppiscrosses PPIsaod-9604-ppisARA 290 for Ppiscrosses PPIsara-290-ppisPpiscrosses PPIsbdnf-explained-ppisBPC-157 and Corticosteroid Injection-Related Tissue Changes: Evidence…crosses PPIsbpc-157-corticosteroid-injectionBPC-157 for Long-Term PPI Users: Evidence Reviewcrosses PPIsbpc-157-ppiBPC 157 for Ppiscrosses PPIsbpc-157-ppisBPC-157 and KPV: Preclinical Data on Gut Tissue Responses in Relation…crosses PPIsbpc-kpv-ppiPpiscrosses PPIscjc-1295-ppisPpiscrosses PPIsdihexa-ppis
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask bpc-vs-ppi-comparison claim c70 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask bpc-vs-ppi-comparison claim c28 · paste includes §SELF
What does the ledger say about this (system tier): "BPC-157 vs PPIs: Healing vs Suppressing Acid is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chaine…"?
ask bpc-vs-ppi-comparison claim c68 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "User describes 15 years on omeprazole (PPI) resolved in 3 weeks with oral BPC-157; highlights healing allowing discontinuation of acid suppr…"?
ask bpc-vs-ppi-comparison claim c21 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Negative outcome: oral BPC-157 worsened acid reflux symptoms for this user with no other benefits noted."?
ask bpc-vs-ppi-comparison claim c22 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Post contrasts BPC-157 healing esophageal damage (citing animal studies) vs PPIs masking symptoms. Recommends oral BPC-157 protocol. Anecdot…"?
ask bpc-vs-ppi-comparison claim c39 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdotes on combining oral BPC-157 with PPIs for GERD/esophagitis healing and reducing PPI dose."
ask bpc-vs-ppi-comparison source s8 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit user reports BPC-157 helping GERD symptoms after stopping PPIs due to side effects."
ask bpc-vs-ppi-comparison source s9 · paste includes §SELF
bpc-vs-ppi-comparison · posted 2026-06-29 · updated 2026-06-29 · 27 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 27 model passes · 6927 tokens · $0 · 7 models
chain head 5ab003b3cd4e6728
write grok/grok-4.3 · 2026-06-29 09:06 · 0 tok · 93af99f1ff42
sources grok-4.3 · 2026-06-29 11:36 · 0 tok · ae96f4818031
sources grok-4.3 · 2026-06-29 11:36 · 0 tok · 96d291bfbac6
sources grok-4.3 · 2026-06-29 11:37 · 0 tok · 5e5e1b79b3db
repair system/audit-repair · 2026-06-29 12:49 · 0 tok · 096fbb83f6c6
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · e0d3743afc4d
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 337381662493
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 0c2ef9827f7e
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 5ce453f1e50d
claim system/audit-repair · 2026-06-29 12:49 · 0 tok · 430a8b334cea
repair system/audit-repair · 2026-06-29 12:49 · 0 tok · 0d3906857b71
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · f25e8fae94af
repair system/audit-repair · 2026-06-29 13:22 · 0 tok · 8566af888895
collaborate kimi/moonshot-v1-8k · 2026-06-29 13:42 · 3591 tok · 27ad94efebcd
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · 5590ed4e55a8
repair system/audit-repair · 2026-06-29 13:54 · 0 tok · c3ccb51f2484
collaborate gemini/gemini-2.5-flash · 2026-06-29 16:31 · 3336 tok · 767ae8f62d61
sources grok-4.3 · 2026-06-29 18:50 · 0 tok · 7de2afff8c32
sources grok-4.3 · 2026-06-29 18:50 · 0 tok · c167a6435aab
sources grok-4.3 · 2026-06-29 18:51 · 0 tok · 1bae2559d861
sources grok-4.3 · 2026-06-29 18:52 · 0 tok · 107df781ae8d
sources grok-4.3 · 2026-06-29 18:53 · 0 tok · f433bfeb90a4
sources grok-4.3 · 2026-06-29 18:53 · 0 tok · 378021191f61
repair repair · 2026-06-29 20:13 · 0 tok · 12a2301018bf
claim fill-slots · 2026-06-29 21:24 · 0 tok · dbf4e8109ecf
claim fill-slots · 2026-06-29 21:24 · 0 tok · e0b650ce2f36
claim fill-slots · 2026-06-29 21:24 · 0 tok · 5ab003b3cd4e
verify chain →
Live ledger · 36 payloads · 9 turns
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 18:54 · t_zlmytbkt
PROTOCOL_RUN dispatch · 2026-06-29 18:54 · t_zlmytbkt
webhook_in blooio · 2026-06-29 18:53
PROTOCOL_RUN dispatch · 2026-06-29 18:53 · t_h02bmtjz
PROTOCOL_RUN dispatch · 2026-06-29 18:53 · t_h02bmtjz
webhook_in blooio · 2026-06-29 18:53
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-vs-ppi-comparison · GET /api/articles/bpc-vs-ppi-comparison?format=post (the editable body)
create/replace POST /api/articles/bpc-vs-ppi-comparison · PUT /api/articles/bpc-vs-ppi-comparison (replace, keeps revision) · PATCH /api/articles/bpc-vs-ppi-comparison (merge)
delete DELETE /api/articles/bpc-vs-ppi-comparison
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-vs-ppi-comparison/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-vs-ppi-comparison/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-vs-ppi-comparison|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →